New drug cocktail shows promise in rare sarcomas
NCT ID NCT04216953
First seen Apr 30, 2026 · Last updated May 12, 2026 · Updated 3 times
Summary
This study tested a combination of two drugs (atezolizumab and cobimetinib) in children and adults with advanced soft tissue sarcoma that had spread. The goal was to see if the combo could shrink or stabilize tumors. About 229 people were enrolled, and the main focus was on how many patients had their cancer stop growing for at least 16 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA,SOFT TISSUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Bérard
Lyon, 69008, France
-
Centre Oscar Lambret
Lille, 59020, France
-
Hôpital de la Timone
Marseille, 13385, France
-
Institut Curie
Paris, France
-
Institut Gustave Roussy
Villejuif, 94800, France
-
Institut de Cancérologie de l'Ouest
Angers, 49055, France
Conditions
Explore the condition pages connected to this study.